Woodline Partners LP Agios Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $19.5 Billion
- Q3 2025
A detailed history of Woodline Partners LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 73,996 shares of AGIO stock, worth $3.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
73,996
Previous 233,068
68.25%
Holding current value
$3.23 Million
Previous $7.75 Million
61.68%
% of portfolio
0.02%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding AGIO
# of Institutions
256Shares Held
63.8MCall Options Held
2.06MPut Options Held
911K-
Farallon Capital Management LLC San Francisco, CA5.78MShares$252 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$212 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.71MShares$162 Million3.19% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.76MShares$121 Million1.05% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.39B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...